Eli Lilly and Cipla announce agreement to distribute and promote tirzepatide in India under the brand name Yurpeak Read more
Novo Nordisk’s Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide: Study Read more
Lilly’s Mounjaro (tirzepatide) demonstrated cardiovascular protection in a head-to-head trial Read more
Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes Read more
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist competition: GlobalData Read more
Viking Therapeutics’ obesity drug could become direct competitor to Eli Lilly’s tirzepatide: GlobalData Read more
Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData Read more